Conversion of Nightingale Health Plc’s EMP shares to Series B shares
Company release, 20 March 2024 at 5:00 p.m. (EET) The Board of Directors of Nightingale Health Plc (“Nightingale Health”) has in its meeting on 18 December 2023, approved request of shareholders to convert 79,765 EMP shares to Series B shares in accordance with Article 5 in the Articles of Association. As a result of conversion of shares, the number of the Nightingale Health’s Series A shares is 20,585,924 and Series B shares is 39,233,735 and EMP shares is 1,098,800. The conversion does not affect the total amount of shares which is 60,918,459. The number of votes of Nightingale